Navigation Links
'Advancements in GYN Oncology; Instrumentation and Techniques' to be Presented by Nicholas C. Lambrou, M.D. of Miami
Date:3/16/2011

MIAMI, March 16, 2011 /PRNewswire/ -- Nicholas C. Lambrou, M.D., FACOG, of Miami Gynecologic Oncology, will present a seminar focusing on the latest advancements in robotic assisted gynecologic oncology surgery with David Kushner, MD, of the University of Wisconsin School of Medicine.

Dr. Lambrou will present to surgeons and surgeon's assistants about minimally invasive procedures performed laparoscopically and robot assisted. His unique operative technique utilizes the latest technology in laparoscopic tissue sealing in combination with robotic-assisted surgical dissection, minimizing blood loss and improving operative efficiency and precision.

The one-day seminar will be held in Cincinnati on March 29th at the Endo-Surgery Institute. It will enable the Gynecologic Oncologist with opportunities to engage in discussions regarding the latest advances in laparoscopic and robot assisted surgery.

The agenda will include:

  • Science of Advanced Energy
  • Advanced Energy Lab
  • Laparoscopic Gynecological Oncology Procedures
  • Robot- assisted Gynecological Oncology Procedures with Advanced Energy Modalities
  • Role of the First Assistant
  • Next Generation Product Development
  • Economics and Healthcare Reform
  • Hands-on Animate Lab
  • Next Steps in the Learning Journey

A leading daVinci robotic assisted surgeon, Dr. Lambrou, was one of the first gynecologic oncologists to be trained in 2006. Since that time, he has performed over 1000 surgeries and has become a widely recognized expert in robotic gynecologic surgery. His specialty includes both surgical and chemotherapy expertise in treating women with gynecologic cancers and is considered a world expert in robotic surgery utilizing the daVinci system.

For more information about Dr. Lambrou, he can be reached in Miami, Florida at (305) 430-6969, or to register for the seminar please call your local Ethicon Endo-Surgery sales representative at 1-800-USE-ENDO.


'/>"/>
SOURCE Miami Gynecologic Oncology
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. New Clinical Studies Presented at the 14th World Congress of Anesthesiology Demonstrate Masimo Advancements in Patient Care
2. ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimers Disease
3. Karmanos Cancer Institute Researchers Present Breast Cancer Advancements at Conference
4. New Heart Ultrasound Research Reveals Life-Saving Treatment Alternatives and Advancements for Heart Patients
5. Amicus Therapeutics Announces Fourth Quarter and Full Year 2009 Financial Results and Highlights Product Pipeline Advancements
6. Ethicon Endo-Surgery Launches EESadvancements.com for Advanced Access to Innovative Solutions
7. Advancements in Technology Benefit Cardiology Patients at Palos Community Hospital
8. Instrumentation Laboratory Receives FDA Clearance for HemosIL RecombiPlasTin 2G Assay
9. Instrumentation Laboratory Installs 2000th ACL TOP(R) System
10. Amerinet Awards Contract to Instrumentation Laboratory for Critical Care Portfolio
11. Instrumentation Laboratory Receives 510(K) Clearance From FDA and Canadian License for HemosIL(R) D-Dimer HS 500 Assay
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... URBANDALE, Iowa , Jan. 18, 2017 /PRNewswire/ ... announced that subsidiary Caretta Therapeutics plans, in the ... product. Venodol, a topical roll-on intended to provide ... to opioid and steroidal analgesics. It was developed ... Reid to commercialize products derived from snake ...
(Date:1/18/2017)... , Jan. 18, 2017  Kratom leaves, from ... family, are often used to prepare tea-like beverages ... several million Americans annually to increase alertness, enhance ... remedy for minor aches and pains. PinneyAssociates, review ... intended to assist FDA and DEA in determining ...
(Date:1/18/2017)... 18, 2017  Dermata Therapeutics, LLC, a biotechnology ... a variety of dermatological diseases, announces dosing the ... a Phase 2 acne rosacea study. DMT210 is ... proinflammatory cytokines in the skin responsible for the ... This clinical trial, DMT210-003, is a ...
Breaking Medicine Technology:
(Date:1/19/2017)... ... January 19, 2017 , ... ... offering treatments for patients with sleep apnea and TMJ disorders. These conditions are ... physical health. Dr. Rassouli provides personalized care to reduce the risk of these ...
(Date:1/19/2017)... ... ... Sam & Associates Insurance Agency, a full service firm providing asset protection ... Area, is launching a charity drive to raise awareness of heart disease risk factors ... killer of adult men and women in America, and is responsible for over 25% ...
(Date:1/19/2017)... Madison, Mississippi (PRWEB) , ... January 19, 2017 , ... ... its Siena Center. , Siena Center is a skilled nursing facility on the grounds ... private and semiprivate rooms. It recently was voted the best nursing home in Mississippi ...
(Date:1/19/2017)... ... January 18, 2017 , ... The CHP suggests that California drivers can avoid ... slowing down and increasing the space between themselves and other vehicles, according to a ... attorney Raymond R. Hassanlou notes that, rain or shine, drivers should always incorporate safe ...
(Date:1/19/2017)... ... January 19, 2017 , ... Sales Focus Inc. (SFI), ... into the US market. , Over the past 20 years SFI has been recognized ... SFI has launched six new clients into the US market. The new clients ...
Breaking Medicine News(10 mins):